Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Entrada Therapeutics Inc shares valued at $476,360 were sold by MPM BIOVENTURES 2018, L.P. on Dec 10 ’24. At $20.77 per share, MPM BIOVENTURES 2018, L.P. sold 22,935 shares. The insider’s holdings dropped to 4,402,849 shares worth approximately $71.41 million following the completion of this transaction.
Also, MPM BIOVENTURES 2018, L.P. sold 21,787 shares, netting a total of over 440,751 in proceeds. Following the sale of shares at $20.23 each, the insider now holds 4,381,062 shares.
Before that, MPM BioVentures 2014, L.P. had sold 22,935 shares from its account. In a trade valued at $476,360, the 10% Owner traded Entrada Therapeutics Inc shares for $20.77 each. Upon closing the transaction, the insider’s holdings decreased to 22,935 shares, worth approximately $71.41 million.
As published in their initiating research note from ROTH MKM on December 06, 2024, Entrada Therapeutics Inc [TRDA] has been a Buy and the price target has been revised to $29. Analysts at Oppenheimer started covering the stock with ‘”an Outperform”‘ outlook in a report released in early January. As of April 03, 2023, H.C. Wainwright has initiated its “Buy” rating for TRDA.
Analyzing TRDA Stock Performance
During the last five days, there has been a drop of approximately -6.19%. Over the course of the year, Entrada Therapeutics Inc shares have dropped approximately -6.19%. Shares of the company reached a 52-week high of $18.76 on 01/03/25 and a 52-week low of $16.19 on 01/08/25. A 50-day SMA is recorded $18.52, while a 200-day SMA reached $16.03. Nevertheless, trading volume fell to 0.11 million shares from 0.12 million shares the previous day.
Support And Resistance Levels for Entrada Therapeutics Inc (TRDA)
According to the 24-hour chart, there is a support level at 15.89, which, if violated, would cause prices to drop to 15.56. In the upper region, resistance lies at 16.85. The next price resistance is at 17.48. RSI (Relative Strength Index) is 35.46 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at -0.26, which suggests the price will decrease in the coming days. Percent R is at 99.02%, indicating bearish price movement. Stochastics %K at holding indicates that the stock is to be held.
